Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

T cell transcriptomes in the course of allogeneic hematopoietic stem cell transplantation II

ABSTRACT: T cell transcriptomes in the course of allogeneic hematopoietic stem cell transplantation II

PROVIDER: PRJNA665411 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12703600.fastq.gz	Fastqsanger.gz
	SRR12703700.fastq.gz	Fastqsanger.gz
	SRR12703800.fastq.gz	Fastqsanger.gz
	SRR12703900.fastq.gz	Fastqsanger.gz
	SRR12704000.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 458

Similar Datasets

T cell transcriptomes in the course of allogeneic hematopoietic stem cell transplantation

Project description:T cell transcriptomes in the course of allogeneic hematopoietic stem cell transplantation

| PRJNA610755 | ENA

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Project description:The aim of this study is to assess the Fecal Microbiota Transplantation (FMT) efficacy in the prevention of allogeneic hematopoietic stem cell transplantation (allo-HSCT) complications and particularly Graft versus Host Disease (GvHD). The hypothesis of this study is that allogeneic FMT may improve outcomes of these patients.

| 2381286 | ecrin-mdr-crc

T cell transcriptomes in the course of allogeneic hematopoietic stem cell transplantation

Project description:RNA seq data of pooled T cells isolated from skin and blood at multiple time points before and after hematopoietic stem cell transplantation

2020-03-07 | GSE146495 | GEO

T cell transcriptomes in the course of allogeneic hematopoietic stem cell transplantation II

Project description:RNA seq data of pooled T cells isolated from skin and blood at multiple time points before and after hematopoietic stem cell transplantation

2021-02-19 | GSE158483 | GEO

Tolerance associated gene expression following allogeneic hematopoietic cell transplantation

Project description:Biologic markers of immune tolerance may facilitate tailoring of immune suppression duration after allogeneic hematopoietic cell transplantation (HCT). In a cross-sectional study, peripheral blood samples were obtained from tolerant (n=15, median 38.5 months post-HCT) and non-tolerant (n=17, median 39.5 post-HCT) HCT recipients and healthy control subjects (n=10) for analysis of immune cell subsets and differential gene expression. There were no significant differences in immune subsets across groups. We identified 281 probe sets unique to the tolerant (TOL) group and 122 for non-tolerant (non-TOL). These were enriched for process networks including NK cell cytotoxicity, antigen presentation, lymphocyte proliferation, and cell cycle and apoptosis. Differential gene expression was enriched for CD56, CD66, and CD14 human lineage-specific gene expression. Differential expression of 20 probe sets between groups was sufficient to develop a classifier with > 90% accuracy, correctly classifying 14/15 TOL cases and 15/17 non-TOL cases. These data suggest that differential gene expression can be utilized to accurately classify tolerant patients following HCT. Prospective investigation of immune tolerance biologic markers is warranted. Samples were collected after allogeneic hematopoietic cell transplantation (HCT) or in healthy control subjects. Peripheral blood samples were obtained from tolerant (n=15, median 38.5 months post-HCT) and non-tolerant (n=17, median 39.5 post-HCT) HCT recipients and healthy control subjects (n=10).

2015-05-25 | E-GEOD-64300 | biostudies-arrayexpress

Single-cell dissection of human hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation

Project description:Single-cell dissection of human hematopoietic reconstitution after allogeneic hematopoietic stem cell transplantation

| PRJNA932251 | ENA

Precup2012 - Mathematical modeling of cell dynamics after allogeneic bone marrow transplantation

Project description:This is a basic mathematical model describing the dynamics of three cell lines (normal host cells, leukemic host cells and donor cells) after allogeneic stem cell transplantation.

2024-09-02 | BIOMD0000000800 | BioModels

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

Project description:Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

| PRJNA947751 | ENA

Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

Project description:Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation

| PRJNA947752 | ENA

Tolerance associated gene expression following allogeneic hematopoietic cell transplantation

2015-05-25 | GSE64300 | GEO